SynthesisThe British journal of dermatology2020

Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS analysis.

J Diels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.